Center for Drug Evaluation and Research (CDER)
July 22, 2025
July 22, 2025
WASHINGTON, July 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter:
* * *
Center for Drug Evaluation and Research (CDER)
*
Recipient:
Recipient Name
Mr. Umesh Gupta
Recipient Title
Senior Vice President and Site Head
Glenmark Pharmaceuticals Limited
Plot No. 2, Phase-II, Pharma Zone, SEZ < . . .
* * *
Center for Drug Evaluation and Research (CDER)
*
Recipient:
Recipient Name
Mr. Umesh Gupta
Recipient Title
Senior Vice President and Site Head
Glenmark Pharmaceuticals Limited
Plot No. 2, Phase-II, Pharma Zone, SEZ < . . .